SCHEMBL3989949

SCHEMBL3989949

CS(=O)(=O)c1cccc(CCOc2cc(-c3cncnc3)nc(N3CCOCC3)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 14/20 0.42
PIK3CG P48736 3/20 0.42
PIK3CB P42338 3/20 0.42
RAF1 P04049 1/20 0.39
BRAF P15056 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MTOR P42345 3/20 0.37
PIK3R1 P27986 2/20 0.37
AKT1 P31749 2/20 0.37
CYP11B2 P19099 1/20 0.37
PIK3CD O00329 1/20 0.37
MAP3K12 Q12852 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13848237 0.91 PIK3CA (0.48) PIK3CAPIK3CGPIK3CBMTORPIK3R1
SCHEMBL4127821 0.82 PIK3CA (0.50) PIK3CAPIK3CGPIK3CBMTORPIK3R1
SCHEMBL4116337 0.77 CYP11B2 (0.60) PIK3CAPIK3CGPIK3CBTSHRMAPK1
SCHEMBL3990409 0.75 PIK3CA (0.58) PIK3CAPIK3CGPIK3CBMTORPIK3R1
SCHEMBL3991137 0.74 PIK3CA (0.49) PIK3CAPIK3CGPIK3CBHSD17B10MTOR
SCHEMBL13848119 0.74 PIK3CA (0.53) PIK3CAPIK3CGPIK3CBMTORPIK3R1
SCHEMBL4126716 0.74 PIK3CA (0.53) PIK3CAPIK3CGPIK3CBMTORPIK3R1
SCHEMBL4117117 0.73 HTR1A (0.47) PIK3CAPIK3CGPIK3CBHSD17B10MTOR
SCHEMBL3990236 0.73 PIK3CA (0.51) PIK3CAPIK3CGPIK3CBCYP1A2CYP2C9
SCHEMBL13848126 0.72 PIK3CA (0.56) PIK3CAPIK3CGPIK3CBMTORPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009066084-A1 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-28 WO claimed